Resiliency in Patients Undergoing Radical Cystectomy for Bladder Cancer

University of Kansas

Status: Completed

Conditions: Bladder Cancer

Study type: Observational

Funder types: Other

Identifiers

NCT06337305

STUDY00146138

Details and patient eligibility

About

This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey. This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life, providing opportunity for future interventional studies.

Full description

This is a prospective cross-sectional survey-based study composed of both a retrospective chart review and 3-series patient survey. This study will help elicit potential areas throughout the perioperative course of radical cystectomy to improve patient resilience and quality of life, providing opportunity for future interventional studies. Primarily, the study will evaluate health related quality of life and resiliency in patients throughout the perioperative course of a radical cystectomy for bladder cancer.

The primary objective will be the correlation of the Connor-Davidson Resilience Scale (CD-RISC-25) and the Functional Assessment of Cancer Therapy-Bladder-Cystectomy (FACT-BL-Cys) score.

Patients will be identified and undergo consent and baseline assessments, including completion of surveys prior to their cystectomy. A retrospective chart review will also be completed to record information regarding patient's cancer stage, treatment status, diagnosis date, insurance type, and related medical conditions and medications. Data from retrospective chart review will be collected and recorded in a secure REDCap database for all eligible patients.

Subsequent surveys will be administered again at approximately 10-30 days postoperatively, as well as 60-120 days postoperatively.

Enrollment: 74 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with a diagnosis of bladder cancer
• Patients electing to undergo radical cystectomy as treatment
• ≥ 18 years of age
• Able to speak and read English
• Willing and able to provide informed consent
• Functioning telephone number or access to one

Exclusion criteria

• Patients opting to not undergo radical cystectomy
• Minors

Trial design

74 participants in 1 patient group

Bladder cancer patients undergoing radical cystectomy.

Description:

This is a prospective cross-sectional survey of bladder cancer patients undergoing radical cystectomy.